← back to search

Dayong Gu

Shantou University · CN
Area of research
Molecular Biology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Advanced biosensing and bioanalysis techniques, Esophageal Cancer Research and Treatment, Zoonotic diseases and public health, and Mosquito-borne diseases and control.
h-index
34
citations
4,102
works
210
NIH funding
primary concept
Medicine
email

Recent publications

C-Reactive Protein: An Important Inflammatory Marker of Coronary Atherosclerotic Disease.
2026cited by 10position: contributordoi
Design, synthesis, and applications of TCR1: A bifunctional aggregation-induced emission fluorescent probe for simultaneous detection of glutathione and viscosity
Dyes and Pigments 2025cited by 5position: middledoi
Tissue Factor Pathway Inhibitor 2 Enhances Hepatocellular Carcinoma Chemosensitivity by Activating CCAR2-GADD45A-Mediated DNA Damage Repair
International Journal of Biological Sciences 2025cited by 3position: middledoi
From bioinformatics to clinical application: A new strategy in CRP detection with peptide aptamer.
2025cited by 2position: contributordoi
Alteration of Ubiquitination in the Brain of ENOPH1 Knockout Mice after Early Ischemic Stroke.
2025cited by 1position: contributordoi
The combination of PD-1 inhibitor with chemotherapy ± salvage chemoradiotherapy for local primary-recurrence esophageal squamous cell carcinoma after definitive chemoradiotherapy: A prospective, multicenter, single-arm clinical study (ESO-Nanjing12).
Journal of Clinical Oncology 2025cited by 0position: middledoi
Structures of CRP antigen-antibody complexes provide insights into the mechanism of specific recognition.
2025cited by 0position: contributordoi
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial
EClinicalMedicine 2024cited by 31position: middledoi
CRISPR-HOLMES-based NAD+ detection
Frontiers in Bioengineering and Biotechnology 2024cited by 18position: middledoi
<scp>TRPM8</scp> overexpression suppresses hepatocellular carcinoma progression and improves survival by modulating the <scp>RTP3</scp>/<scp>STAT3</scp> pathway
Cancer Medicine 2024cited by 1position: middledoi
Cytoplasm Hydrogelation-Mediated Cardiomyocyte Sponge Alleviated Coxsackievirus B3 Infection.
2023cited by 3position: contributordoi
DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis.
2022cited by 89position: contributordoi
Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer
JAMA Network Open 2022cited by 72position: middledoi
Definition of CRISPR Cas12a Trans-Cleavage Units to Facilitate CRISPR Diagnostics
Frontiers in Microbiology 2021cited by 76position: middledoi
Definition of CRISPR Cas12a <i>T</i> <i>rans</i>-Cleavage Units to Facilitate CRISPR Diagnostics.
2021cited by 54position: contributordoi
Recent Improvements in CRISPR-Based Amplification-Free Pathogen Detection.
2021cited by 21position: contributordoi
Comparative analysis of carbapenemases, RND family efflux pumps and biofilm formation potential among Acinetobacter baumannii strains with different carbapenem susceptibility.
2021cited by 19position: contributordoi
Downregulation of lncRNA EPB41L4A-AS1 Mediates Activation of MYD88-Dependent NF-κB Pathway in Diabetes-Related Inflammation.
2021cited by 18position: contributordoi
Distribution pattern of carbapenemases and solitary contribution to resistance in clinical strains of Acinetobacter baumannii.
2021cited by 9position: contributordoi
The Global Infectious Diseases Epidemic Information Monitoring System: Development and Usability Study of an Effective Tool for Travel Health Management in China.
2021cited by 5position: contributordoi
Analysis of Differentially Expressed Novel MicroRNAs as Potential Biomarkers in Dengue Virus Type 1 Infection.
2021cited by 3position: contributordoi
Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.
2021cited by 2position: contributordoi
[Application of iPDMS protein microarray in screening of tumor-associated antigen autoantibodies].
2021cited by 1position: contributordoi
[Application of SPR protein chip in screening for imported malaria].
2021cited by 1position: contributordoi
Spectrum of respiratory tract infections in travelers entering mainland China: Shenzhen port of entry, China, 2013-2014.
2021cited by 0position: contributordoi
Automated multiplex nucleic acid tests for rapid detection of SARS-CoV-2, influenza A and B infection with direct reverse-transcription quantitative PCR (dirRT-qPCR) assay in a centrifugal microfluidic platform
RSC Advances 2020cited by 59position: lastdoi
A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection.
2020cited by 34position: contributordoi
Antibody-free rapid diagnosis of malaria in whole blood with surface-enhanced Raman Spectroscopy using Nanostructured Gold Substrate.
2020cited by 11position: contributordoi
Development of a Pulsed Xenon Ultraviolet Disinfection Device for Real-Time Air Disinfection in Ambulances.
2020cited by 9position: contributordoi
CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7.
2019cited by 51position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2015–2020)Jinjun Ye · Guangzhou University of Chinese Medicine3 papers (2022–2025) · 3 papers (2017–2020)Guoren Zhou · Sun Yat-sen University Cancer Center3 papers (2022–2025)Hongzhong Zhou · Wenzhou Medical University3 papers (2024–2025)Dongmei Gou · Nanjing Tech University2 papers (2024–2025) · 2 papers (2015–2017)Dashan Ai · Shanghai Medical College of Fudan University2 papers (2022–2024)Kuaile Zhao · Shanghai Medical College of Fudan University2 papers (2022–2024)Jianning Song · Guangzhou Medical University2 papers (2024–2025)Jin Wang · Xi'an University of Science and Technology2 papers (2020–2024)Lang Li · Guangzhou University of Chinese Medicine2 papers (2019–2020)Zhen Zhang · Suzhou Municipal Hospital2 papers (2022–2024)Jiancheng Li · Yangtze University2 papers (2022–2025)Lei Shi · Kunming University of Science and Technology2 papers (2015–2017)Miao Mo · Fudan University2 papers (2022–2024)Yong Xu · Chinese Academy of Sciences2 papers (2021–2024)Haohua Zhang · Jinan University2 papers (2024–2025)Lichan Chen · University of Minnesota, Twin Cities2 papers (2024–2025)Zhi Zhang · Guizhou University2 papers (2022–2024)